Biotechnology News and Research

RSS

New study explains how pathogenic bacteria digest ethanolamine

A new study, led by researchers at the University of Liverpool, has revealed how pathogenic bacteria construct tiny protein-based compartments, known as Eut microcompartments, which enable them to digest ethanolamine - a nutrient commonly found in the gut.

3 Oct 2025

Scientists discover new protein family regulating motility and DNA uptake

Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire network of RNA-protein interactions inside human cells - an achievement that could offer new strategies for treating diseases ranging from cancer to Alzheimer's.

3 Oct 2025

The World Vaccine Congress heads to Amsterdam, where it will draw experts and leaders from science, academia, start-ups, biotechnology and pharmaceutical companies making this event Europe’s most attractive R&D conference

Sessions will cover topics from Clinical Development to Bioprocessing & Manufacturing to Cancer Immunotherapy and much more.

From World Vaccine Congress Europe 2 Oct 2025

How the University of Manchester used Bruker equipment to map the dynamics of complex protein

Discover how Bruker and the University of Manchester joined forces to discover more on the dynamics of complex protein.

From Bruker BioSpin Group 2 Oct 2025

Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling

The mechanical properties of tissue matrix are crucial for maintaining cell health and function. With aging, tissue matrix loses its mechanical integrity and exhibits altered biophysical properties, which are closely associated with various diseases including neurodegenerative diseases and cancers.

30 Sep 2025

High-resolution imaging reveals how polymyxins trigger rapid shedding of bacterial armor

A team led by UCL (University College London) and Imperial College London researchers has shown for the first time how life-saving antibiotics called polymyxins pierce the armor of harmful bacteria.

30 Sep 2025

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models.

26 Sep 2025

AI-guided platform improves design and efficiency of therapeutic nanoparticles

Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial intelligence (AI) to design nanoparticles for drug delivery.

24 Sep 2025

Groundbreaking discovery could transform leishmaniasis treatment

Leishmaniasis, a neglected tropical disease prevalent across 90 countries, affects approximately 12 million people worldwide, with 350 million more at risk of infection.

24 Sep 2025

Senescent cell subtypes do not respond equally to treatment, study shows

A new research paper was published in Volume 17, Issue 8 of Aging-US on August 7, 2025, titled "Senescent cell heterogeneity and responses to senolytic treatment are related to cell cycle status during senescence induction."

23 Sep 2025

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of NK.SET™.

23 Sep 2025

UC Davis wins NSF grants to advance AI-driven protein engineering

Two projects at the University of California, Davis, that use artificial intelligence to design and engineer proteins for industrial and health applications have been funded by the U.S. National Science Foundation (NSF).

19 Sep 2025

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study published in The Lancet Neurology.

18 Sep 2025

CRISPR-based tongue swab test shows promise for tuberculosis detection

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based screenings for the world's deadliest infectious disease.

17 Sep 2025

Breakthrough in building functional synthetic kidneys using assembloids

A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys.

17 Sep 2025

Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has completed a financing round, extending its total Series A funding to $19 million.

17 Sep 2025

CRISPR-GPT helps scientists to generate designs, analyze data and troubleshoot design flaws

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments.

16 Sep 2025

Triple negative breast cancer exploits lymph node niches to block immune defense

In almost all solid tumors - i.e. cancers with a solid tissue structure - the detection of tumor cells in the lymph nodes is considered a decisive marker for the progression of the disease.

16 Sep 2025

Children show high exposure to PFAS despite regulatory restrictions

These chemical compounds are highly stable and linger in the environment. Thanks to their water-, oil- and stain-repellent properties, they are widely found in everyday items, such as non-stick pans, waterproof clothing, food containers and fire-fighting foams.

15 Sep 2025

Unlocking hidden soil microbes for new antibiotics

Most bacteria cannot be cultured in the lab-and that's been bad news for medicine. Many of our frontline antibiotics originated from microbes, yet as antibiotic resistance spreads and drug pipelines run dry, the soil beneath our feet has a vast hidden reservoir of untapped lifesaving compounds.

13 Sep 2025

Biotechnology News and Research

New study explains how pathogenic bacteria digest ethanolamine

Scientists discover new protein family regulating motility and DNA uptake

The World Vaccine Congress heads to Amsterdam, where it will draw experts and leaders from science, academia, start-ups, biotechnology and pharmaceutical companies making this event Europe’s most attractive R&D conference

How the University of Manchester used Bruker equipment to map the dynamics of complex protein

Tissue-mimicking hydrogels drive cell reprogramming via matrix remodeling

High-resolution imaging reveals how polymyxins trigger rapid shedding of bacterial armor

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

AI-guided platform improves design and efficiency of therapeutic nanoparticles

Groundbreaking discovery could transform leishmaniasis treatment

Senescent cell subtypes do not respond equally to treatment, study shows

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

UC Davis wins NSF grants to advance AI-driven protein engineering

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

CRISPR-based tongue swab test shows promise for tuberculosis detection

Breakthrough in building functional synthetic kidneys using assembloids

Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline

CRISPR-GPT helps scientists to generate designs, analyze data and troubleshoot design flaws

Triple negative breast cancer exploits lymph node niches to block immune defense

Children show high exposure to PFAS despite regulatory restrictions

Unlocking hidden soil microbes for new antibiotics

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News